Serum sFlt-1, cystatin C and cathepsin B are potential severity markers in preeclampsia: a pilot study.

Ye Sul ParkYezi KimHo-Yeon KimKi-Hoon AhnGeum Joon ChoSoon-Cheol HongMin-Jeong OhHai-Joong Kim

Published in: Archives of gynecology and obstetrics (2020)

In addition to sFlt-1 levels, the serum levels of cathepsin B and cystatin C significantly change when preeclampsia develops. These markers are associated with severity markers of elevated blood pressure and liver injury in preeclampsia.

Keyphrases

liver injury
early onset
drug induced
blood pressure
pregnancy outcomes
type diabetes
heart rate
pregnant women
risk assessment
skeletal muscle
insulin resistance
glycemic control